Open Access

Introduction.

Topic: Lipid-Lowering Agents
Organised by PACE-CME - Supported by an unrestricted educational grant from Amarin Pharma

Congress Presentation

About the speaker

Professor Lina Badimon

Cardiovascular Program-ICCC, IR-Hospital de la Santa Creu i Sant Pau, UAB, CIBERCV, Barcelona (Spain)
16 presentations
1 follower

4 more presentations in this session

ASCVD & residual risk: recent clinical insights with icosapent ethyl.

Speaker: Professor D. Bhatt (Boston, US)

Thumbnail

A continuum of multifactorial benefits of icosapent ethyl.

Speaker: Professor M. Back (Stockholm, SE)

Thumbnail

Integrating icosapent ethyl in clinical practice: which patients will benefit?

Speaker: Professor S. Verma (Toronto, CA)

Thumbnail

Discussion.

Speaker: Professor L. Badimon (Barcelona, ES)

Thumbnail

Access the full session

New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice

Speakers: Professor L. Badimon, Professor D. Bhatt, Professor M. Back, Professor S. Verma, Professor L. Badimon
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk